Many (38.5%) of our neonatal classic CTLN1 patients (P1–P5) were homozygous for a common mutation of ASS1 (c.1168G>A; p.Gly390Arg), which caused the most fulminant disease course, leading to liver failure and early neonatal death despite treatment. The gene discussed is ASS1; the disease is Hepatic failure.